Εξώφυλλο

Analysis of baseline laboratory characteristics of HIV-positive patients in Bulgaria treated with bictegravir /emtricitabine/ tenofovir anafelamide (early analysis)

<p>Introduction: Bictegravir/Emtricitabine/Tenofovir Anafelamide (B/F/TAF) is a recommended single tablet regimen with good tolerability and safety as well as durability of the virologic response. From its introduction in the country of Bulgaria in April 2021 till November 2021 it was given to...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Dimitar Strashimirov (Συγγραφέας), Ralitsa Yordanova (Συγγραφέας), Rusina Grozdeva (Συγγραφέας), Evgeni Penchev (Συγγραφέας), Daniel Ivanov (Συγγραφέας), Nina Yancheva-Petrova (Συγγραφέας)
Μορφή:	Βιβλίο
Έκδοση:	Annals of Antivirals and Antiretrovirals - Peertechz Publications, 2024-01-04.
Θέματα:	Research Article
Διαθέσιμο Online:	Connect to this object online.
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice
από: Canetti D, κ.ά.
Έκδοση: (2023)

Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH)
από: Anna Gidari, κ.ά.
Έκδοση: (2023)

Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid
από: Eric H. Decloedt, κ.ά.
Έκδοση: (2021)

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV
από: Oliver T. Stirrup, κ.ά.
Έκδοση: (2019)

Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
από: Juday T, κ.ά.
Έκδοση: (2013)

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults
από: Wissam K. Kabbara, κ.ά.
Έκδοση: (2015)

Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention
από: Meredith R. Clark, κ.ά.
Έκδοση: (2014)

Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptives
από: James AM, κ.ά.
Έκδοση: (2013)

InterPrEP. Internet-based pre-exposure prophylaxis with generic tenofovir DF/emtricitabine in London: an analysis of outcomes in 641 patients
από: Isaac Aloysius, κ.ά.
Έκδοση: (2017)

A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention
από: Erick Leung, κ.ά.
Έκδοση: (2023)

Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as maintenance treatment of patients with HIV and HBV co-infection
από: Y.-S. Huang, κ.ά.
Έκδοση: (2019)

Proton therapy for head and neck cancer therapy: A real-world data case study from Bulgaria
από: Maria Dimitrova, κ.ά.
Έκδοση: (2024)

Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
από: Squillace N, κ.ά.
Έκδοση: (2018)

Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments
από: Simone Perazzolo, κ.ά.
Έκδοση: (2020)

PROBLEMS AND PERSPECTIVES FOR THE LABOUR MARKET IN HEALTH CARE BULGARIA AS A PART OF THE EUROPEAN UNION AND THE COMMUNITY POLICIES
από: Neli Gradinarova, κ.ά.
Έκδοση: (2018)

Evaluation of urinary excretion of dolutegravir or emtricitabine/tenofovir/elvitegravir/cobicistat antiretroviral-based regimens using plasma and urine trough concentration
από: Jérémy Lourenco, κ.ά.
Έκδοση: (2018)

Estimating the budget impact of adopting tenofovir/emtricitabine for pre-exposure prophylaxis of HIV in the public health sector in Namibia (2021 - 2023)
από: Enos Moyo, κ.ά.
Έκδοση: (2022)

A Comparison between the Efficiency of Vonavir (Tenofovir-Emtricitabine- Efavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran
από: Saeideh Honarmand, κ.ά.
Έκδοση: (2022)

Stability-indicating method development and validation for the concurrent determination of darunavir, cobicistat, emtricitabine and tenofovir alafenamide by UPLC in bulk and tablet dosage forms
από: M. Satya Venkata Sakuntala, κ.ά.
Έκδοση: (2021)

Analysis of the Household and Health Care System Expenditures in Bulgaria
από: Zornitsa Mitkova, κ.ά.
Έκδοση: (2021)

Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
από: Ranzenigo M, κ.ά.
Έκδοση: (2022)

ANALYSIS OF ADOLESCENTS' (11-14 YEARS OLD) SOMATOTYPE IN PLOVDIV, BULGARIA
από: Gergana Petrova
Έκδοση: (2020)

Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
από: Ranzenigo M, κ.ά.
Έκδοση: (2022)

Statutory health insurance-covered pre-exposure prophylaxis in Germany: changing trends in nationwide tenofovir disoproxil/emtricitabine prescriptions during the COVID-19 pandemic
από: Henrieke Prins, κ.ά.
Έκδοση: (2023)

Bictegravir and Metformin Drug-Drug Interaction in People with Human Immunodeficiency Virus (HIV)
από: Anne M. Masich, κ.ά.
Έκδοση: (2023)

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
από: Restelli U, κ.ά.
Έκδοση: (2017)

A novel simultaneous high performance liquid chromatography-PDA method for the determination of Tenofovir AF, Darunavir, Emtricitabine and Cobicistat in bulk and its application to marketed formulation
από: Challamalla Pavani, κ.ά.
Έκδοση: (2022)

Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
από: Chang Huang, κ.ά.
Έκδοση: (2023)

A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model
από: Haneesha Mohan, κ.ά.
Έκδοση: (2022)

Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1
από: Donga P, κ.ά.
Έκδοση: (2023)

Cost-effectiveness of treatment intervention in prediabetic patients in Bulgaria
από: Stanislava Yordanova, κ.ά.
Έκδοση: (2023)

HEALTH SERVICES CONSUMPTION AND BARRIERS IN THE HEALTH CARE OF PERSONS OF ROMA ORIGIN IN BULGARIA
από: Mariela Kambouraova, κ.ά.
Έκδοση: (2024)

Emtricitabine-induced pure red cell aplasia
από: Nithendra Manickchund, κ.ά.
Έκδοση: (2019)

STUDY OF THE NUTRITIONAL BEHAVIOR AS A RISKY HEALTH FACTOR OF ADOLESCENTS FROM DIFFERENT ETHNIC GROUPS IN THE MUNICIPALITY OF PLOVDIV, BULGARIA
από: Gergana Petrova, κ.ά.
Έκδοση: (2022)

Аn affordability of statins therapy - comparative analysis between Ukraine and Bulgaria
από: Oksana Tkachova, κ.ά.
Έκδοση: (2019)

ARTERIO-VENOUS FISTULA CREATION FOR HEMODIALYSIS. WHAT IS HAPPENING IN BULGARIA?
από: Biser K. Borisov, κ.ά.
Έκδοση: (2023)

Analysis Of Patients' Opinion Of Prescribed Medicines: A Questionnaire - Based Pilot Study In Bulgaria
από: Zornitsa Emilova Mitkova, κ.ά.
Έκδοση: (2023)

New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria
από: Maria Kamusheva, κ.ά.
Έκδοση: (2020)

THE PREVALENCE AND SEVERITY OF DEPRESSION AND ANXIETY IN HEART FAILURE PATIENTS IN BULGARIA
από: Vasil Kolev, κ.ά.
Έκδοση: (2023)

HIV-1 subtypes distributed among the heterosexsual population in Bulgaria
από: Ivailo Alexiev, κ.ά.
Έκδοση: (2018)